RNA Foci Formation in a Retinal Glial Model for Spinocerebellar Ataxia Type 7

Area of Science:

• Neurodegenerative diseases
• Molecular genetics
• Cell biology

Background:

• Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder impacting the cerebellum and retina.
• Caused by expanded CAG repeats in the ATXN7 gene, leading to polyglutamine expansion in ataxin-7.
• The role of mutant RNA and glial cell involvement in SCA7 retinopathy is not fully understood.

Purpose of the Study:

• To investigate the molecular mechanisms of SCA7 pathogenesis in glial cells.
• To develop an inducible SCA7 model using Müller glial cells (MIO-M1).
• To explore the potential of mutant RNA as a biomarker for SCA7.

Main Methods:

• Generation of an inducible SCA7 model using the MIO-M1 glial cell line.
• Analysis of nuclear and cytoplasmic RNA foci in glial cells.
• Examination of alternative splicing defects.
• Detection of RNA foci in peripheral mononuclear leukocytes from SCA7 patients.

Main Results:

• The SCA7 glial cell model exhibited nuclear and cytoplasmic RNA foci.
• Subtle alternative splicing defects were observed in the MIO-M1 cells.
• RNA foci were detected in leukocytes from SCA7 patients, suggesting biomarker potential.

Conclusions:

• The developed glial cell model recapitulates key molecular features of SCA7.
• Mutant RNA foci are present in SCA7 patient cells and may serve as a blood biomarker.
• This model facilitates the study of RNA toxicity and therapeutic strategies for SCA7.